European guidelines on upper tract urothelial carcinomas: 2013 update. - Wikidata - wikimedia - TriplyDB

European guidelines on upper tract urothelial carcinomas: 2013 update.

European guidelines on upper tract urothelial carcinomas: 2013 update.

http://www.wikidata.org/entity/Q38094307

about

Systemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder Cancer Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma Upper urinary tract disease: what we know today and unmet needs Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population Standards of the Polish Ultrasound Society - update. Ultrasound examination of the kidneys, ureters and urinary bladder.A Pilot Study of In Vivo Confocal Laser Endomicroscopy of Upper Tract Urothelial Carcinoma.Nephroureterectomy surgery in the UK in 2012: British Association of Urological Surgeons (BAUS) Registry data.Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data.Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma.Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer : A population-based study.Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.Ureter regeneration-the proper scaffold has to be defined.Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma.Diffusion-weighted MRI as a potential imaging biomarker reflecting the metastatic potential of upper urinary tract cancer.Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes.The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis.Recent advances in ureteral tissue engineering.The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence Squamous cell carcinoma in a duplicated renal pelvis.Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.[Elective organ and function preservation in ureter and renal pelvis tumors].Miniature forward-viewing common-path OCT probe for imaging the renal pelvis High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.The effect of intravesical chemotherapy in the prevention of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis.Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma.Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.The role of diagnostic ureteroscopy in the era of computed tomography urography.

P2860

Q26765951-8BB1F515-EEF2-4BD0-9E3F-BCE48658F8DD Q26772220-5A32CBF7-748A-41CF-B0AD-ACBB2A38E652 Q26773671-B55947B3-C6A5-4259-A51B-610BABC5CF19 Q28066806-B556B6BC-78A3-4774-A31F-27070758C4E5 Q28067471-9EF8A71C-E460-4C7D-BD9B-1CDDA157C01A Q28076041-4C2713F3-0224-4DA2-8127-C279128477BD Q28077825-48916D1F-4B5A-4424-9ECB-DD02A6D94F27 Q28392404-42C29425-59EE-483F-B4D9-1F2821019B70 Q30396120-7D6A99F6-DD2A-4FB0-BB02-689066A713E9 Q30688672-7A8CD668-7EEC-4387-922A-430A509EB595 Q30829545-136DB214-5E1F-4F58-BCA6-45CDFDD6E65D Q31103185-A7748C1D-A41C-46C9-81BD-258220FE1D02 Q33760541-6148687D-069A-458F-9275-4AC05BE9BB55 Q33820638-613DAB15-82FA-43F5-BA6D-45EA383C6301 Q33840690-AFFA9987-F6FA-43C2-BB97-2CB708D08981 Q33841250-AD349B73-FE33-4E19-9B76-5762256656A4 Q34080219-BEADC3D0-9404-48F0-A0D8-1F57D58C5150 Q34097580-38A264A7-8953-4445-AEA1-899A7C0D546C Q34142394-C06A86BE-358E-4E65-9AF3-6EF757ECC301 Q34223163-D13E0C0A-B973-4320-94D4-9C6B2DCDBC82 Q34436049-5DB450AD-29A7-4369-8AFB-644E5BA36BA9 Q34437835-A4587511-D36E-4271-B5D8-063812E13AF8 Q34528395-3A6A0459-C5C7-4F17-8146-2377D4889ABA Q34602179-DEF82819-23ED-4B10-9C6D-B092D7516FA1 Q34732812-437F3560-EF05-4337-BD3D-315C08C79DD0 Q34962464-AD508DA0-8C99-43BE-BDEE-2C51761FDCE1 Q35016935-1A8C9BE7-CA6D-4C06-B00D-63B7229625BF Q35068013-63171282-3A58-4C6D-B21C-3081CA3DD275 Q35086043-262D7A69-FCFB-46DE-92D9-77FAED0B1B5D Q35230042-6B8767C5-9268-4F5E-8DEB-F1C013A2ADF8 Q35445526-66CA343F-7719-4456-A505-8DF618FC0F41 Q35609624-C8288998-69A2-4CE7-95D2-D3DE5F9EBD59 Q35629317-36C07537-03D8-4697-AE45-906E2765A44E Q35644091-6EA748CB-18F6-4AC0-AA33-791A92EE1C71 Q35682594-45795B73-75DF-46A2-AD27-7C424E47BCEE Q35690319-9263241B-8E14-4C65-82F7-5530CB8696CE Q35808709-D4C62803-3699-4FBF-A693-A63A96AAF689 Q35837779-B0D54DE0-CEE0-48B3-BBEE-04E780361C4B Q35877277-F5A96419-BE09-449B-B278-8514DE1B95AD Q35888994-8700EC91-6E81-483F-9813-E2721E59F15D

P2860

European guidelines on upper tract urothelial carcinomas: 2013 update.

http://www.wikidata.org/entity/Q38094307

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

European guidelines on upper tract urothelial carcinomas: 2013 update.

@en

type

label

European guidelines on upper tract urothelial carcinomas: 2013 update.

@en

prefLabel

European guidelines on upper tract urothelial carcinomas: 2013 update.

@en

P1433

Q38094307-4B277D4D-9D80-405B-91FF-EA8771434114

P1476

Q38094307-8056D3B5-2B3D-4B7A-8EA1-202CA59DDFA4

P2093

Q38094307-0F3996E3-DFDF-4C4D-AE5A-A05B19025900

Q38094307-15D8DBE8-EE28-4567-9FE6-3D7928690C99

Q38094307-1EE75161-87AA-4C66-A554-6945E4B627E1

Q38094307-2A4FCCFD-0E78-4E01-89F1-D7B37E6C233B

Q38094307-5B081531-DC94-4E9B-8071-73F9A30E8C73

Q38094307-7408B92C-659A-4A26-B04A-44A14FC0A9D3

Q38094307-995D9CC6-0415-4274-B30B-5BB4DBB9DFFB

Q38094307-9B507DFD-8026-42F7-884D-270EFDBE8AE0

Q38094307-A8A2DF35-EA66-4478-B14A-4DC0E6B0F37C

Q38094307-BF233805-5258-43AC-BD37-75A184EEABBF

P304

Q38094307-00FB8174-2E00-4F54-B724-FAC4BB20F77D

P31

Q38094307-B4357788-550F-4685-AF45-D2834CC8D304

P356

Q38094307-F110F947-1D8F-4516-9A23-3AC4E615D015

P407

Q38094307-D46CD273-AE66-4F4C-8596-49B312D018FA

P433

Q38094307-F42F8D49-31B0-4F41-AF35-9E8A9621ADFD

P478

Q38094307-07B7773A-2020-4D51-9524-AC8F6D102710

P577

Q38094307-36001477-8433-46C7-8313-D30029847E1A

P698

Q38094307-6D288156-6E2D-4DF8-8267-913C69840E50

P356

J.EURURO.2013.03.032

P1433

European Urology

P1476

European guidelines on upper tract urothelial carcinomas: 2013 update.

@en

P2093

Andreas Böhle

http://www.w3.org/2001/XMLSchema#string

Bas W G Van Rhijn

http://www.w3.org/2001/XMLSchema#string

Eero Kaasinen

http://www.w3.org/2001/XMLSchema#string

European Association of Urology

http://www.w3.org/2001/XMLSchema#string

Eva Compérat

http://www.w3.org/2001/XMLSchema#string

Joan Palou

http://www.w3.org/2001/XMLSchema#string

Marko Babjuk

http://www.w3.org/2001/XMLSchema#string

Max Burger

http://www.w3.org/2001/XMLSchema#string

Morgan Rouprêt

http://www.w3.org/2001/XMLSchema#string

Nigel Cowan

http://www.w3.org/2001/XMLSchema#string

P304

1059-1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2013.03.032

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23540953

http://www.w3.org/2001/XMLSchema#string